← Browse by Condition
Medical Condition

relapse multiple myeloma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06138275 Phase 2
Recruiting

Elranatamab in R/R Multiple Myeloma

Enrollment
32 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →